Rationale for the use of multiple blockers of the renin--angiotensin--aldosterone system in specific patient populations

Author： Hage Fadi G   Mansur Sulaf J   Oparil Suzanne  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.3, 2011-05, pp. : 227-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Renin-Angiotensin-Aldosterone System: Approaches to Guide Angiotensin-Converting Enzyme Inhibition in Patients with Coronary Artery Disease

By  

Cardiology, Vol. 112, Iss. 4, 2008-10 ,pp. : 303-312

Karger

Access to resources Recommend Favorite

Analytical Review of the Evidence for Renoprotection by Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease – A Call for Caution

By  

Nephron Clin Pract, Vol. 113, Iss. 2, 2009-07 ,pp. : c63-c70

Karger

Access to resources Recommend Favorite

Polymorphisms in genes of the renin‐angiotensin‐aldosterone system and renal cell cancer risk: Interplay with hypertension and intakes of sodium, potassium and fluid

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 5, 2015-03 ,pp. : 1104-1116

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Relation between Renin-Angiotensin-Aldosterone System Blockade and Contrast-Induced Nephropathy: An Unresolved Issue

By  

Cardiology, Vol. 130, Iss. 1, 2014-11 ,pp. : 1-3

Karger

Access to resources Recommend Favorite

Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 2, 2011-05 ,pp. : 134-146

Bentham Science Publishers

Access to resources Recommend Favorite